(Q34052859)

30 July 2017

1 reference

title

Cytokines and advanced cancer (English)

1 reference

30 July 2017

Dunlop RJ

1

1 reference

30 July 2017

Campbell CW

series ordinal

2

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Journal of Pain and Symptom Management

30 July 2017

published in

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

214-232

1 reference

Cytokines in tumour growth, migration and metastasis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The use of cytokines in the treatment of solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Neuroimmunomodulation via limbic structures--the neuroanatomy of psychoimmunology

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Immunoregulators in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cytokines of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cytokines: the kidney as a model for their role in tissue injury and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Endotoxin-induced cytokine gene expression and excretion in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Growth Factor Synthesis and Human Breast Cancer Progression

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Angiogenesis: models and modulators.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-6 enhances motility of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Serum levels of interleukin 6 in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Fever: role of pyrogens and cryogens

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin 1 receptor blockade attenuates the host inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Angiogenic factors as tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Clinical toxicity of cytokines used as haemopoietic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Neuropsychiatric disorders in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Anorexia during acute and chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cytokine-to-brain communication: a review & analysis of alternative mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

A phase I trial of intravenous interleukin-6 in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Tumor necrosis factor and the acute metabolic response to tissue injury in man

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Lipid mobilising factors specifically associated with cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Antiemetics: neurotransmitter receptor binding predicts therapeutic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Fasting, Feeding and Regulation of the Sympathetic Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Central action of recombinant interleukin-1 to inhibit acid secretion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Neurohormonal control of intestinal transit

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Human recombinant interleukin 1 beta suppresses acetylcholine release from rat myenteric plexus.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The role of cytokines in muscle wasting: its relation with cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The acute metabolic effects of tumor necrosis factor administration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Insomnia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Bradykinin initiates cytokine-mediated inflammatory hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Direct spinal pathways to the limbic system for nociceptive information

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Hypothalamic and thalamic sites of action of interleukin-1 beta on food intake, body temperature and pain sensitivity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Distribution and axonal relations of macrophages in a neuroma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Transection or electrical stimulation of the hypoglossal nerve increases glial fibrillary acidic protein immunoreactivity in the hypoglossal nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The response of central glia to peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Orthostatic hypotension in bronchial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Impaired neuroglial activation in interleukin-6 deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cytokines which signal through the LIF receptor and their actions in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Astrocytic neurotransmitter receptors in situ and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The relationship of nausea and dyspnea to pain in seriously ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Sickness behavior as a new target for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Possible association of interleukin-2 treatment with depression and suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Sleep patterns in patients with cancer and patients with cardiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Assessment of sleep in patients with lung cancer and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Endogenous sleep-promoting substances and sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Phase II clinical trial of high-dose recombinant human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Central nervous system toxicity of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Neurological effects of recombinant human interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cognitive deficits in patients with small cell lung cancer before and after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Chronic Deafferentation of Human Spinal Cord Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Passage of cytokines across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: correlation of SPECT with neuropsychological testing

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interferon enhances the excitability of cultured neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 beta has excitatory effects on neurons of the bed nucleus of the stria terminalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Blockade by interleukin-1 receptor antagonist of IL-1 beta-induced neuronal activity in guinea pig preoptic area slices

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The effects of interleukin 1 beta on the hypothalamic tachykinin, neurokinin A

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

The neurochemistry of central pain: evidence from clinical studies, hypothesis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Nitric oxide and fibroblast growth factor in autonomic nervous system: short- and long-term messengers in autonomic pathway and target-organ control

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Transforming growth factor-betas in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Dehydration and the dying patient

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Disturbed fluid and electrolyte homoeostasis following dehydration in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Reduced thirst after water deprivation in healthy elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Cytokine-induced programmed death of cultured sympathetic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900199-8

7 January 2021

10.1016/S0885-3924(00)00199-8

Identifiers

DOI

1 reference

30 July 2017

1 reference